# Adolescent Medicine Trials Network for HIV/AIDS Interventions (ATN) Operations and Collaborations Center (UM2 Clinical Trial Optional)

> **NIH NIH UM2** · WESTAT, INC. · 2024 · $7,583,126

## Abstract

ABSTRACT – OVERALL
Adolescents and young adults (AYA) ages 13-24 accounted for 21% of new HIV diagnoses in the United
States in 2019. New infections in AYA disproportionately affect Black, Latino, multiracial, and American
Indian/Alaska Native men who have sex with men. Geographic areas of the United States are also
disproportionately affected by new infections: Northeast > South > West followed by the Midwest. The specific
aim of the applicant is to serve as the Operations and Collaborations Center (OCC) of the Adolescent Trials
Network (ATN). Westat is in an ideal position to expertly perform the ATN OCC scope of work (SOW) as
outlined in RFA-HD-23-021 due to our prior and current successful experience supporting HIV pediatric and
adolescent research programs. The newly designed ATN network will be made up of a Scientific Leadership
Center (SLC) and OCC. As the OCC, Westat will work collaboratively with the ATN SLC and provide
operational and logistical infrastructure to support the ATN Executive Committee (EC). This is critical to the
EC's success in achieving its scientific leadership agenda and in its collaborations with the ATN External
Scientific Panel (ESP), National Institutes of Health (NIH) program staff, and external research networks and
investigators. The overall aims of the ATN OCC are to: (1) Provide administrative management and coordinate
Network external collaborations; (2) Provide operational support for cross-network protocols, collaborations,
and other projects (e.g., conduct trainings, develop manuals of operation, Network public support relations,
provide Network website maintenance, support communications and conference calls, convening committees
and meetings); (3)Train Network participants on a breadth of research-related topics; (4) Manage resources
and execute performance-based subcontracts with site consortiums, vendors, and collaborators; (5) Provide
regulatory infrastructure for cross-network protocols, collaborations, and emerging projects (e.g., site
performance monitoring, quality assurance procedures, and protocol registration); (6) Provide mechanisms and
metrics to monitor subject screening, recruitment, retention, and dropout, and procedures for adjustment if
enrollment targets are not being met; (7) Provide detailed systems for tracking study progress and
performance of site consortia and reporting to the EC (e.g., support of a study progress and performance
monitoring committee). Routine tracking and reporting will include defined metrics, milestones, timelines, and
quality-control measures to ensure studies stay on track and within budget. Relevance: Westat will provide the
appropriate technical, organizational, administrative expertise, and resources to efficiently design, implement,
and simultaneously manage a broad portfolio of therapeutic, behavioral, and community studies. Study findings
will be used to develop interventions for reducing HIV transmission and acquisition among AYA, safe and
effective f...

## Key facts

- **NIH application ID:** 10880572
- **Project number:** 5UM2HD111076-03
- **Recipient organization:** WESTAT, INC.
- **Principal Investigator:** Barbara Driver
- **Activity code:** UM2 (R01, R21, SBIR, etc.)
- **Funding institute:** NIH
- **Fiscal year:** 2024
- **Award amount:** $7,583,126
- **Award type:** 5
- **Project period:** 2022-09-22 → 2029-06-30

## Primary source

NIH RePORTER: https://reporter.nih.gov/project-details/10880572

## Citation

> US National Institutes of Health, RePORTER application 10880572, Adolescent Medicine Trials Network for HIV/AIDS Interventions (ATN) Operations and Collaborations Center (UM2 Clinical Trial Optional) (5UM2HD111076-03). Retrieved via AI Analytics 2026-05-26 from https://api.ai-analytics.org/grant/nih/10880572. Licensed CC0.

---

*[NIH grants dataset](/datasets/nih-grants) · CC0 1.0*